Rosenberg, Texas (August 28, 2020) - The United States Food & Drug Association (“FDA”) has recently issued warning letters to various companies concerning misleading statements regarding COVID-19 claims. These claims surrounded the use of hypochlorous acid in the prevention of COVID-19. As quoted from FDA communications: “There are currently no FDA approved products to prevent or treat COVID-19.”
EKKDA Research, LLC, an ophthalmic-focused research and development company based in Kingsland, Texas is pleased to announce a sales-distribution agreement has been reached with OCuSOFT Inc.
During the COVID 19 pandemic, we are urged to avoid touching our eyes, nose, and mouth; to clean our hands frequently; and to clean all surfaces in our environment. There are many sanitizers that can be used on our hands only; OCuSOFT HypoChlor can be used on our hands and can also be sprayed onto our faces prior to and after wearing a mask. It can even be used to spray down the mask after use.
Alan G. Kabat, OD, FAAO - As news of COVID-19, the worldwide pandemic associated with severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) continues to dominate the headlines well into April of 2020, eye care providers have witnessed a tremendous alteration of their practices and lifestyles.
OCuSOFT® is committed to giving the ophthalmic community unparalleled support in the coming days, weeks and months. We remain open to ship to all of our customers to deliver safe, reliable and affordable products to the community by taking measures to help slow the spread of the virus, while at the same time allowing us to maintain the continuity of our business as much as possible.
It is important to note that this recall is being issued to the RETAIL LEVEL and WILL NOT AFFECT PATIENTS OR CONSUMERS. Accordingly, no further communication or retrieval to or from patients/consumers is required. RETAIL, in this instance, is by way of definition, a recall of existing inventory and as previously noted would not affect your patients.
OCuSOFT Inc., an R&D focused eye and skin care products company, in a joint venture with Essentia Pharma, a marketing and investment subsidiary of OCuSOFT®, is pleased to announce it has acquired the intellectual property portfolio of Digital Heat Corporation, a science and technology—based company located in Phoenix, Arizona.
OCuSOFT Inc. is pleased to announce the availability of new OCuSOFT® Lid Scrub® Allergy Eyelid Cleanser for allergy conditions in convenient pre-moistened pads.
Companies that excel at employee relations, use innovation to motivate employees, implement creative compensation programs and more will be recognized by National Association for Business Resources (NABR) at the Houston’s Best and Brightest Companies to Work For® symposium and awards gala on Thursday, March 28, 2019 at the Marriott Houston West Loop Galleria.
Long-time Prevent Blindness partner, OCuSOFT® Inc., a privately-held eye and skin care company dedicated to innovation in eyelid hygiene and ocular health, will support April’s Women’s Eye Health and Safety Month by donating 10 percent of all online sales during the month of April.